Medication management among home-dwelling older patients with chronic diseases: Possible roles for community pharmacists

Journal of Nutrition, Health and Aging

Volumn 16, Issue 8, 2012, Pages 721-726

  Mehuys, E ^a   DuponD, L ^a   Petrovic, M ^b   Christiaens, T ^a   Van BortEL, L ^c   Adriaens, E ^a   De BoLLE, L ^a   Van Tongelen, I ^a   Remon, J P ^a   BoussEry, K ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Community pharmacy; Home dwelling elderly; Medication management; Pharmaceutical care

Indexed keywords

AGENTS AFFECTING LIPID METABOLISM; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL STIMULANT AGENT; DIURETIC AGENT; DRUG; PSYCHOTROPIC AGENT;

AGED; ARTICLE; ATTITUDE TO HEALTH; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; DRUG PACKAGING; DYSPHAGIA; FEMALE; GERIATRIC PATIENT; HOMEBOUND PATIENT; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PHARMACIST; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; TABLET; VISUAL DISORDER;

EID: 85027928033     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-012-0028-x     Document Type: Article

References (38)

1. Routledge PA, O'Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J clin pharmacol 2004;57(2):121-6. (Pubitemid 38223523)
2. Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drugs aging 2004;21(12):793-811. (Pubitemid 39423335)
3. Mestdagh J, Lambrecht M. The agir project: ageing, health and retirement in Europe. Use of health care and nursing care by the elderly: Data for Belgium. Brussels: Federal planning Bureau 2003.
4. Barat I, Andreasen F, Damsgaard EM. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J clin pharmacol 2000;56(6-7):501-9.
5. Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: what doctors believe and patients actually DO. Br J clin pharmacol 2001;51(6):615-22. (Pubitemid 32862751)
6. Tordoff JM, Bagge ML, Gray AR, Campbell AJ, Norris PT. Medicine-taking practices in community-dwelling people aged > or =75 years in new Zealand. Age ageing 2010;39(5):574-80.
7. Castelino RL, Bajorek BV, chen tF. Retrospective evaluation of home medicines review by pharmacists in older australian patients using the medication appropriateness index. Ann pharmacother 2010;44(12):1922-9.
8. Castelino RL, Hilmer SN, Bajorek BV, Nishtala P, Chen TF. Drug Burden index and potentially inappropriate medications in community-dwelling older people: the impact of home Medicines review. Drugs aging 2010;27(2):135-48.
9. Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, et al. Does home based medication review keep older people out of hospital? the hoMEr randomised controlled trial. BMJ 2005;330(7486):293.
10. Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care-the poLyMED randomised controlled trial. Age ageing 2007;36(3):292-7. (Pubitemid 47072323)
11. Vinks TH, Egberts TC, de Lange TM, de Koning FH. Pharmacist-based medication review reduces potential drug-related problems in the elderly: the sMog controlled trial. Drugs aging 2009;26(2):123-33.
12. Modig S, Kristensson J, Ekwall AK, Hallberg IR, Midlov P. Frail elderly patients in primary care-their medication knowledge and beliefs about prescribed medicines. Eur J clin pharmacol 2009;65(2):151-5.
13. Borson S, Scanlan JM, Chen P, Ganguli M. The Mini-cog as a screen for dementia: validation in a population-based sample. J am geriatr soc 2003;51(10):1451-4. (Pubitemid 37259876)
14. Aparasu RR, Mort JR, Brandt H. Psychotropic prescription use by community-dwelling elderly in the united states. J am geriatr soc 2003;51(5):671-7. (Pubitemid 36541432)
15. Assem-hilger E, Jungwirth S, Weissgram S, Kirchmeyr W, Fischer P, Barnas C. Benzodiazepine use in the elderly: an indicator for inappropriately treated geriatric depression? int J geriatr psychiatry 2009;24(6):563-9.
16. Demyttenaere K, Bonnewyn A, Bruffaerts R, De girolamo G, Gasquet I, Kovess V, et al. Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (EsEMeD). J affect Disord 2008;110(1-2):84-93.
17. Mhaolain AN, Gallagher D, o'connell H, Chin AV, Bruce I, Hamilton F, et al. Benzodiazepine use amongst community dwelling elderly: 10 years ON. Int J geriatr psychiatry 2010;25(6):650-1.
18. Fourrier A, Letenneur L, Dartigues JF, Moore N, Begaud B. Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J clin pharmacol 2001;57(5):419-25. (Pubitemid 33787193)
19. International narcotics control Board (incB), united nations. Technical report: psychotropic substances. 2010.
20. Madhusoodanan S, Bogunovic oJ. Safety of benzodiazepines in the geriatric population. Expert opin Drug saf 2004;3(5):485-93. (Pubitemid 39242722)
21. Nhs guidance For prescribing and Withdrawal of Benzodiazepines & hypnotics in general practice. Version 1 Date october 2006, review date october 2008.
22. Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J prim health care 2003;21(3):153-8. (Pubitemid 37174004)
23. Bjorkman IK, Fastbom J, Schmidt IK, Bernsten cB. Drug-drug interactions in the elderly. Ann pharmacother 2002;36(11):1675-81. (Pubitemid 35265600)
24. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the united states. JaMa 2008;300(24):2867-78.
25. Secoli SR, Figueras A, Lebrao ML, de Lima FD, Santos JL. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study. Drugs aging 2010;27(9):759-70.
26. Tulner LR, Frankfort SV, Gijsen GJ, van Campen JP, Koks CH, Beijnen JH. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs aging 2008;25(4):343-55. (Pubitemid 351440452)
27. Blix HS, Viktil KK, Moger TA, Reikvam A. Identification of drug interactions in hospitals-computerized screening VS. Bedside recording. J clin pharm ther 2008;33(2):131-9. (Pubitemid 351341404)
28. Bergk V, Gasse C, Rothenbacher D, Loew M, Brenner H, Haefeli WE. Drug interactions in primary care: impact of a new algorithm on risk determination. Clin pharmacol ther 2004;76(1):85-96. (Pubitemid 38844737)
29. Van Eijken M, Tsang S, Wensing M, de Smet PA, Grol RP. Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature. Drugs aging 2003;20(3):229-40. (Pubitemid 36269584)
30. Lakey SL, Gray SL, Borson S. Assessment of older adults' knowledge of and preferences for medication management tools and support systems. Ann pharmacother 2009;43(6):1011-9.
31. Huang HY, Maguire MG, Miller ER, 3rd, Appel LJ. Impact of pill organizers and blister packs on adherence to pill taking in two vitamin supplementation trials. Am J Epidemiol 2000;152(8):780-7.
32. Park DC, Morrell RW, Frieske D, Kincaid D. Medication adherence behaviors in older adults: effects of external cognitive supports. Psychol aging 1992;7(2):252-6.
33. Ware GJ, Holford NH, Davison JG, Harris RG. Unit dose calendar packaging and elderly patient compliance. N Z Med J 1991;104(924):495-7.
34. Saverno KR, Hines LE, Warholak TL, Grizzle AJ, Babits L, Clark C, et al. Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions. J am Med inform assoc 2011;18(1):32-7.
35. George J, Elliott RA, Stewart DC. A systematic review of interventions to improve medication taking in elderly patients prescribed multiple medications. Drugs aging 2008;25(4):307-24. (Pubitemid 351440449)
36. De Gier N, Gorgels W, Lucassen P, Oude voshaar R, Mulder J, Zitman F. Discontinuation of long-term benzodiazepine use: 10-year follow-up. Fam pract 2010.
37. Gorgels WJ, oude voshaar RC, Mol AJ, van de Lisdonk EH, van Balkom AJ, van den hoogen HJ, et al. Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study. Drug alcohol Depend 2005;78(1):49-56. (Pubitemid 40354176)
38. Geersh AB, Bouvy ML. Minimal intervention in a cohort of chronic benzodiazepine users. Results after three years of follow-up. PW Wetenschappelijk platform. 2009;3(4):62-66.